In nonalcoholic steatohepatitis (NASH) models, the downregulation or absence of AGER1 decreased SLC7A11 expression, thereby inducing hepatocyte injury and exacerbating liver fibrosis [90]. The gene discussed is SLC7A11; the disease is Hepatic fibrosis.